Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2017.21
PubMed Identifier: 28196063
Publication URI: http://europepmc.org/abstract/MED/28196063
Type: Journal Article/Review
Volume: 116
Parent Publication: British journal of cancer
Issue: 6
ISSN: 0007-0920